TiumBio
1 Decision Maker · 1 Verified Contact
tiumbio.com
About TiumBio
TiumBio is a drug developer working on treatments for cancer.
Key Facts
- Industry
- Finance & Banking
- Founded
- 2016
- Headquarters
- Seongnam, Kyonggi-do, South Korea
- Company size
- 51-100 employees
- Website
- tiumbio.com
- Operating status
- Active
- Phone
- 031-600-1500
- Company Type
- For Profit
- Last Funding Type
- Post-IPO Equity
- Stock Symbol
- KOSDAQ:321550
- Last Investment Activity
- Mar 11, 2024
- Investments Activity
- Mar 11, 2024, Dec 29, 2023, Dec 29, 2023
- Phone Number
- 031-600-1500
Leadership & Decision Makers
Contact details of 1 TiumBio decision makers
Kim Hun-taek
Founder & CEO
No contact data available
General Emails
General company emails, e.g. customer support lines
dongwoo@tiumbio.com
recruit@tiumbio.com
Technical Team
nce401_tu2218@tiumbio.com
relationsdayesong@tiumbio.com
junseokjang@tiumbio.com
Similar Companies like TiumBio
Team8
team8.vc
HQ: Tel Aviv-yafo, Tel Aviv, Israel
Sequoia Capital
sequoiacap.com
HQ: Menlo Park, California, United States
Citi Venture Capital International
citi.com
HQ: New York, NY
Blackstone Group
blackstone.com
HQ: New York, NY
BMO Nesbitt Burns
bmo.com
HQ: Toronto, Ontario, Canada
Frequently Asked Questions about TiumBio
What does TiumBio do?
TiumBio is a drug developer working on treatments for cancer.
Where is TiumBio headquartered?
TiumBio is headquartered in Seongnam, Kyonggi-do, South Korea.
When was TiumBio founded?
TiumBio was founded in 2016.
How many employees does TiumBio have?
TiumBio has approximately 51-100 employees.
What industry is TiumBio in?
TiumBio operates in the Finance & Banking industry.
How do I contact TiumBio?
You can contact TiumBio via email at dongwoo@tiumbio.com or recruit@tiumbio.com, headquartered in Seongnam, Kyonggi-do, South Korea.